Myeloid Therapeutics

Daniel Getts, Ph.D., Founder and CEO

Oct. 10 | 1:30pm | Rentschler ATMP Ballroom

Cambridge, MA


Myeloid Therapeutics is a clinical-stage, immune-cell programming company, focused on new treatment options for patients with solid tumors. The Company designs and deploys its proprietary mRNA-coded CARs for in vivo programming of immune cells.

By using this website you agree to accept our Privacy Policy and Terms & Conditions